Clinical trial
A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
NCT02080377 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- March 31, 2016
- Enrollment
- 23 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
gestational diabetes, pregnancy